Hantavirus Infection: A Possible Cause of Delayed Sensorineural Hearing Loss

Zaki SR Greer PW Coffield LM Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995; 146:552–79.

Hantavirus potential occupational health and safety concern. Occupational and Environmental Health Services, Health Canada, 1994.

Hjelle B Jenison S Mertz G Emergence of hantaviral disease in the southwestern United States. West J Med 1994; 161: 467–73.

Duchin JS Koster FT Peters CJ Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus study group. N Engl J Med 1994; 330:949–55.

Ksiazek TG Peters CJ Rollin PE Identification of a new North American Hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg 1995; 52:117–23.

Chapman LE Khabbaz RF Etiology and epidemiology of the Four Corners hantavirus outbreak. Infect Agents Dis 1994; 3: 234–44.

Nerurkar VR Song JW Song KJ Genetic evidence for a hantavirus enzootic in deer mice (P. maniculatus) captured a decade before the recognition of hantavirus pulmonary syndrome. Virology 1994; 204:563–8.

Singh AE Werker DH Boychuk LR Miedzinski LJ Hantavirus pulmonary syndrome: report of four Alberta cases. Can J Infect Dis 1995; 6:184–90.

Hjelle B Jenison S Torrez-Martinez N A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States; evolutionary relationships to known hantaviruses. J Virol 1994; 68:592–6.

Harris JP Endres DR Medical therapy of sensorineural hearing loss. In: English GM , ed. Otolaryngology Philadelphia: Harper and Row; 1992. p. 1–16.

Gulya AJ Sensorineural hearing losses of adulthood. In: Cummings CW Fredrickson JM Harker LA , editors. Otolaryngology head and neck surgery. St. Louis: Mosby-Year Book; 1993. p. 3113–26.

Govaerts PJ Claes J van de Heyning PH Aminoglycoside-induced ototoxicity [Letter]. Toxicology 1990; 52:227–51.

Brummett RE Fox KE Aminoglycoside-induced hearing loss in humans. Antimicrob Agents Chemother 1980; 33:797–800.

Matz GJ Aminoglycoside ototoxicity. Am J Otolaryngol 1986; 7:117–9.

Ballantyne J. Ototoxicity. J Laryngol Otol 1983; 97(suppl):9–12.

Fee WE Aminoglycoside ototoxicity in the human. Laryngoscope 1980; 10:1–19.

Federspil P. Drug-induced sudden hearing loss and vestibular disturbances. Adv Otorhinolaryngol 1981; 27:144–58.

Johnson JT Kamerer DB Aminoglycoside ototoxicity. An update, with implications for all drug therapies. Postgrad Med 1985; 77:131–8.

Brummett RE Drug-induced ototoxicity. Drugs 1980; 19:412–28.

D'Alonzo BJ Cantor AB Ototoxicity: etiology and issues. J Fam Pract 1983; 16:489–94.

Kerr AG Scott-Brown's otolaryngology. 5th ed. London: Butterworth and Co; 1987. p. 390–1.

Wilson WR Veltri RW Laird N Sprinkle PM Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 1983; 91:653–8.

Morrison YY Rathbun RC Hantavirus pulmonary syndrome: the Four Corners disease. Ann Pharmacother 1995; 29:57–65.

Cohen MS Kwei HE Chin CC Ge HC CNS manifestations of epidemic hemorrhagic fever. An advanced manifestation of disease associated with poor prognosis. Arch Intern Med 1983; 143: 2070–2.

Everberg G. Deafness following mumps. Acta Otol 1981; 48: 397–9.

Fausti SA Henry JA Schaffer HI High frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis 1992; 165:1026–32.

Henley CM Ryback LP Developmental ototoxicity [Review]. Otolaryngol Clin North Am 1993; 26:857–71.

Spiropoulou CE Morzunou S Feldmann H Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994; 200:715–23.